参考文献

［1］MARCHESE M J，HALL E J，HILARIS B S.Encapsulated iodine-125 in radiation oncology.I.Study of the relative biological effectiveness（RBE）using low dose rate irradiation of mammalian cell cultures.Am J Clin Oncol，1984，7（6）：607-611.

［2］FREEMAN M L，GOLDHAGEN P，SIERRA E，et al.Studies with encapsulated 125I sources.Ⅱ.Determination of the relative biological effectiveness using cultured mammalian cells.Int J Radiat Oncol Biol Phys，1982，8（8）：1355-1361.

［3］DALE R G.The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy.Br J Radiol，1985，58（690）：515-528.

［4］DASILVA V F，GUTIN P H，DEEN D F，et al.Relative biological effectiveness of 125I sources in a murine brachytherapy model.Int J Radiat Oncol Biol Phys，1984，10（11）：2109-2111.

［5］DALE R G.Radiobiological assessment of permanent implants using tumour repopulation factors in the linear-quadratic model.Br J Radiol，1989，62（735）：241-244.

［6］HENSCHKE U K，LAWRENCE D C.Caesium-137 seeds for permanent implants.Radiology，1985，1117-1119.

［7］HALL E J.Radiation dose-rate：a factor of importance in radiobiology and radiotherapy.Br J Radiol，1972，45（530）：81-97.

［8］LING C C.Permanent implants using 198Au，103Pa and 125I：Radiobiological considerations based on the liner quadratic model.Int J Radiat Oncol Biol Phys，1984，10：2109-2111.

［9］MARCHESE M J，ZAIDER M，HALL E J.Dose-rate effects in normal and malignant cells of human origin.Br J Radiol，1987，60（714）：573-576.

［10］DASILVA V F，GUTIN P H，DEEN D F，et al.Relative biological effectiveness of 125I sources in a murine brachytherapy model.Int J Radiat Oncol Biol Phys，1984，10（11）：2109-2111.

［11］OUYANG L，SHI Z，ZHAO S，et al.Programmed cell death pathways in cancer：a review of apoptosis，autophagy and programmed necrosis.Cell Prolif，2012，45（6）：487-498.

［12］ODONKOR C A，ACHILEFU S.Modulation of effector caspase cleavage determines response of breast and lung tumor cell lines to chemotherapy.Cancer Invest，2009，27（4）：417-429.

［13］赵真真，王忠敏，陆健，等.125I粒子持续低剂量率照射和（60）Coγ射线高剂量率照射对H1299细胞生物学效应的比较研究 .介入放射学杂志，2015，24（8）：702-706.

［14］QUA，WANG H，LI J，et al.Biological effects of（125）I seeds radiation on A549 lung cancer cells：G2/M arrest and enhanced cell death.Cancer Invest，2014，32（6）：209-217.

［15］WANG J，WANG J，LIAO A，et al.The direct biologic effects of radioactive 125I seeds on pancreatic cancer cells PANC-1，at continuous low-dose rates.Cancer Biother Radiopharm，2009，24（4）：409-416.

［16］LIAO A，WANG J，WANG J，et al.Relative biological effectiveness and cell-killing efficacy of continuous low-dose-rate 125I seeds on prostate carcinoma cells in vitro.Integr Cancer Ther，2010，9（1）：59-65.

［17］LIU J S，CHIANG T H，WANG J S，et al.Induction of p53-independent growth inhibition in lung carcinoma cell A549 by gypenosides.J Cell Mol Med，2015，19（7）：1697-1709.

［18］GROEGER A M，ESPOSITO V，DELUCA A，et al.Prognostic value of immunohistochemical expression of p53，bax，Bcl-2 and Bcl-xL in resected non-small-cell lung cancers.Histopathology，2004，44（1）：54-63.

［19］KUBO N，NODA S E，TAKAHASHI A，et al.Radiosensitizing effect of carboplatin and paclitaxel to carbon-ion beam irradiation in the non-small-cell lung cancer cell line H460.J Radiat Res，2015，56（2）：229-238.

［20］CAI Y，SHENG Z Y，CHEN Y，et al.Effect of Withaferin A on A549 cellular proliferation and apoptosis in non-small cell lung cancer.Asian Pac J Cancer Prev，2014，15（4）：1711-1714.

［21］WANG Z M，LU J，LIU T，et al.CT-guided interstitial brachytherapy of inoperable non-small cell lung cancer.Lung Cancer，2011，74（2）：253-257.

［22］JOHNSON M，COLONIAS A，PARDA D，et al.Dosimetric and technical aspects of intraoperative I-125 brachytherapy for stage I non-small cell lung cancer.Phys Med Biol，2007，52（5）：1237-1245.

［23］SANTOS R，COLONIAS A，PARDA D，et al.Comparison between sublobar resection and 125Iodine brachytherapy after sublobar resection in high-risk patients with Stage I non-small-cell lung cancer.Surgery，2003，134（4）：691-697.